Stemrim
A biotech company aiming to develop regeneration-inducing medicines.
Market cap
$148m
Enterprise value
$84m
Share price
JPY305.00 4599.T
loading funding rounds…
Kyogin Lease & Capital(exited)
Kanagawa Science Park(exited)
Miyako Capital(exited)
SMBC Venture Capital(exited)
Kyoto University(exited)
Nippon Venture Capital(exited)
Daiwa Corporate Investment(exited)
Shionogi(exited)
M3(exited)
PF Capital(exited)
SMBC Nikko Securities(exited)
Mitsubishi UFJ Capital(exited)
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (33 %) | (98 %) | 10128 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 18 % | (39 %) | (8368 %) | 8 % | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 17 % | (42 %) | (8480 %) | 7 % | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 65 % | 109 % | 6186 % | 67 % | - |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.